Gene: ALDH1A3
Official Full Name: aldehyde dehydrogenase 1 family member A3provided by HGNC
Gene Summary: This gene encodes an aldehyde dehydrogenase enzyme that uses retinal as a substrate. Mutations in this gene have been associated with microphthalmia, isolated 8, and expression changes have also been detected in tumor cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO39050 | ALDH1A3 Knockout cell line (HeLa) | Human | ALDH1A3 | 1:3~1:6 | Negative | Online Inquiry |
KO39051 | ALDH1A3 Knockout cell line (HCT 116) | Human | ALDH1A3 | 1:2~1:4 | Negative | Online Inquiry |
KO39052 | ALDH1A3 Knockout cell line (HEK293) | Human | ALDH1A3 | 1:3~1:6 | Negative | Online Inquiry |
KO39053 | ALDH1A3 Knockout cell line (A549) | Human | ALDH1A3 | 1:3~1:4 | Negative | Online Inquiry |
ALDH1A3 Gene Knockout Cell Lines are innovative cellular models created through the precise and targeted disruption of the aldehyde dehydrogenase 1A3 (ALDH1A3) gene. This gene plays a critical role in the metabolism of retinoids, which are vital for various biological processes including vision, cellular growth, and differentiation. The knockout of ALDH1A3 results in the alteration of metabolic pathways involving retinoic acid, thereby enabling researchers to explore its functional implications in development, cancer biology, and neurodegenerative diseases.
The primary function of these knockout cell lines is to serve as a tool for studying the effects of ALDH1A3 deficiency. Researchers capitalize on the absence of this gene to analyze changes in cellular behavior, signal transduction pathways, and metabolic shifts. These alterations are crucial for elucidating the role of retinoic acid in cellular processes, highlighting the potential pathophysiological consequences of its dysregulation.
Scientifically, ALDH1A3 Gene Knockout Cell Lines are invaluable in both research and clinical settings. They facilitate the investigation of retinoid signaling pathways, which have significant implications for understanding diseases such as cancer, where ALDH enzymes are often implicated in tumor progression and resistance to therapy. Furthermore, they can be utilized in drug discovery processes, as their responses to new pharmacological agents can reveal potential therapeutic targets.
What sets our ALDH1A3 Gene Knockout Cell Lines apart from other available models is the precision of their development, coupled with validation of their functional profiles, which provides researchers with reliable data. Our cell lines are rigorously characterized, ensuring reproducibility and consistency in experimental outcomes.
These unique attributes make ALDH1A3 Gene Knockout Cell Lines an indispensable asset to any laboratory focused on advancing knowledge in cellular metabolism and therapeutic interventions. Our company is committed to providing high-quality biological products backed by extensive expertise in genetic engineering and cellular biology, ensuring that researchers and clinicians have access to the best tools for their innovative studies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.